Literature DB >> 7198192

The clinical spectrum of hexosaminidase deficiency diseases.

W G Johnson.   

Abstract

Hexosaminidase deficiency diseases or GM2-gangliosidoses were originally described as infantile encephalopathies. Recently, hexosaminidase deficiencies have been found with different phenotypes, including juvenile and adult encephalopathies, cerebellar ataxias, and motor neuron diseases. Individual cases have resembled Ramsey-Hunt syndrome, olivopontocerebellar ataxia, Friedreich ataxia, amyotrophic lateral sclerosis, Kugelberg-Welander disease, Fazio-Londe disease, and Charcot-Marie-Tooth disease. Tremor, dystonia, spastic paresis, and psychosis have been seen. Since few diagnosable causes for these system atrophies are known, these patients should be tested for hexosaminidase deficiency. These recessive disorders fit a multiple loci/multiple alleles genetic scheme, and a clinical genetic classification is presented.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7198192     DOI: 10.1212/wnl.31.11.1453

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  An adult onset hexosaminidase A deficiency syndrome with sensory neuropathy and internuclear ophthalmoplegia.

Authors:  D Barnes; V P Misra; E P Young; P K Thomas; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-12       Impact factor: 10.154

Review 2.  Immunology of amyotrophic lateral sclerosis.

Authors:  N R Cashman; M E Gurney; J P Antel
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Degenerative neurological disorders associated with deficiency of glutamate dehydrogenase.

Authors:  V S Kostić; L Mojsilović; M Stojanović
Journal:  J Neurol       Date:  1989-02       Impact factor: 4.849

4.  Generalized dystonia, whispering dysphonia and Wilson's disease in members of the same family.

Authors:  R Elwes; M Saunders
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-01       Impact factor: 10.154

5.  Hexosaminidase A deficiency presenting as juvenile progressive dystonia.

Authors:  R J Hardie; E P Young; J A Morgan-Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-03       Impact factor: 10.154

6.  Gene transfer corrects acute GM2 gangliosidosis--potential therapeutic contribution of perivascular enzyme flow.

Authors:  M Begoña Cachón-González; Susan Z Wang; Rosamund McNair; Josephine Bradley; David Lunn; Robin Ziegler; Seng H Cheng; Timothy M Cox
Journal:  Mol Ther       Date:  2012-03-27       Impact factor: 11.454

7.  An unusual association of dentato-rubral degeneration with spinal ataxia, ophthalmoplegia and multiple cranial nerve palsies.

Authors:  R C Janzer; F Barontini
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

8.  Morphological study on the hereditary neurogenic amyotrophic dogs: accumulation of lipid compound-like structures in the lower motor neuron.

Authors:  S Izumo; F Ikuta; A Igata; M Osame; C Yamauchi; S Inada
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

9.  GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.

Authors:  S S Raghavan; A Krusell; J Krusell; T A Lyerla; E H Kolodny
Journal:  Am J Hum Genet       Date:  1985-11       Impact factor: 11.025

Review 10.  Ganglioside function in the development and repair of the nervous system. From basic science to clinical application.

Authors:  S D Skaper; A Leon; G Toffano
Journal:  Mol Neurobiol       Date:  1989       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.